Epalrestat的例句大全

The effect of atorvastatin and epalrestat on vascular smooth muscle cell

阿托伐他汀联用依帕司他对血管平滑肌细胞的影响

inhibition effect of atorvastatin and epalrestat on rat vascular restenosis

阿托伐他汀与依帕司他联用抑制大鼠血管再狭窄

pharmacokinetics of epalrestat after a single and multiple oral dose in healthy volunteers

依帕司他单剂量与多剂量给药的药代动力学研究

inhibition effect of epalrestat on rat lens osmotic expansion

依帕司他对大鼠晶状体渗透性膨胀的抑制作用

conclusion the established hplc assay was accurate and convenient for clinical pharmacokinetic study of epalrestat.

结论本研究建立的HPLC测定方法专属性较好，血浆中杂质不干扰样品的测定，适合于依帕司他的临床药动学研究。

bioequivalence of aldose reductase inhibitor epalrestat capsule and tablet in human

醛糖还原酶抑制剂依帕司他胶囊和片剂的人体生物等效性

epalrestat can improve oxidative stress in diabetics and inhibit the nonenzymatic glycation of protein.

依帕司他可减轻糖尿病个体的氧化应激，并抑制蛋白非酶糖化。

pharmacologic actions and clinical utility of epalrestat

依帕司他的药理作用及临床应用

with a low incidence of adverse reactions, epalrestat is an effective and safe drug for chronic diabetic complications, especially diabetic neuropathy.

依帕司他的不良反应发生率低，是一种对糖尿病慢性并发症（特别是糖尿病神经病变）有效且安全的药物。

conclusion: epalrestat can enhance gastric motility and improve dysfunction of the regulation of vagal and sympathetic nerves system. it is safe and effective in treatment of dgp.

结论：依帕司他具有促胃动力和改善交感、迷走神经平衡失调的作用，是治疗DGP安全、有效的药物。

epalrestat was taken as the positive control. the inhibitory type, ki and ic_ ( 50) were determined by double reciprocal plot, quadratic drawing, and drawing of inhibitor's concentration to inhibitory ratio, respectively.

阳性对照为依帕司他，采用双倒数作图的方法确定抑制类型，二次作图法求Ki，以抑制剂浓度对抑制率作图求IC50。

effects of epalrestat on aldose reductase activity, ultrastructural pathology and apoptosis in the renal tissues of diabetic rats

依帕司他对糖尿病大鼠肾脏醛糖还原酶活性、细胞凋亡及超微结构的影响

AIM : To observe the effects of epalrestat in treating diabetic gastroparesis ( DGP ) and auto-nomic neuropathy.

目的: 观察依帕司他对糖尿病性胃轻瘫 ( DGP ) 和 自主 神经病变的影响.